Qiong Pan

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Venues

Nature communications

Hepatology (Baltimore, Md.)

EMBO molecular medicine

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Liangjun Zhang, Pingfan Xie, Mingqiao Li, Xiaoxun Zhang, Shuke Fei, Nan Zhao, Ling Li, Ziqian Xu, Wan Tang, Guanyu Zhu, Zhixian Zhu, Zuzhi Xu, Jian-Wei Li, Chengcheng Zhang, James L Boyer, Wensheng Chen, Shi-Ying Cai, Qiong Pan, Jin Chai
Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation. Hepatology (Baltimore, Md.) (2024)
Liangjun Zhang, Qiong Pan, Lu Zhang, Haihan Xia, Junwei Liao, Xiaoxun Zhang, Nan Zhao, Min Liao, Ya Tan, Qiao Li, Jinfei Zhu, Ling Li, Shijun Fan, Jian-Wei Li, Chengcheng Zhang, Shi-Ying Cai, James L Boyer, Jin Chai
Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling. Hepatology (Baltimore, Md.) (2023)
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Ming-Hua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N Assis, Shi-Ying Cai, James L Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Unique DUOX2 + ACE2 + small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nature communications 14 (1) (2023)
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Ming-Hua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N Assis, Shi-Ying Cai, James L Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Unique DUOX2 + ACE2 + small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nature communications 14 (1) (2023)
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Ming-Hua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N Assis, Shi-Ying Cai, James L Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Unique DUOX2 + ACE2 + small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nature communications 14 (1) (2023)
Liangjun Zhang, Qiong Pan, Lu Zhang, Haihan Xia, Junwei Liao, Xiaoxun Zhang, Nan Zhao, Min Liao, Ya Tan, Qiao Li, Jinfei Zhu, Ling Li, Shijun Fan, Jian-Wei Li, Chengcheng Zhang, Shi-Ying Cai, James L Boyer, Jin Chai
Runt-related transcription factor-1 ameliorates bile acid-induced hepatic inflammation in cholestasis through JAK/STAT3 signaling. Hepatology (Baltimore, Md.) (2023)
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Ming-Hua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N Assis, Shi-Ying Cai, James L Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Unique DUOX2 + ACE2 + small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nature communications 14 (1) (2023)
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Ming-Hua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N Assis, Shi-Ying Cai, James L Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Unique DUOX2 + ACE2 + small cholangiocytes are pathogenic targets for primary biliary cholangitis. Nature communications 14 (1) (2023)
Xiaoxun Zhang, Ling Li, Nan Zhao, Qiong Pan, Liangjun Zhang, Qiaoling Xie, Xuan Li, Min Liao, Qiao Li, Xinglin Huang, Sheng Chen, Jianwei Li, Huaizhi Wang, Xuequan Huang, Shijun Fan, Yunxia Wang, Man Li, Jin Chai
A novel role for interleukin 32 in cholestasis. Clinical and translational medicine 11 (11) (2022)
Qiong Pan, Gang Luo, Jiaquan Qu, Sheng Chen, Xiaoxun Zhang, Nan Zhao, Jingjing Ding, Hong Yang, Mingqiao Li, Ling Li, Ying Cheng, Xuan Li, Qiaoling Xie, Qiao Li, Xueqian Zhou, Huiling Zou, Shijun Fan, Lingyun Zou, Wei Liu, Guohong Deng, Shi-Ying Cai, James L Boyer, Jin Chai
A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis. EMBO molecular medicine 13 (11) (2021)

Qiong Pan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Qiong Pan